Statement of Deviation & Variation for the quarter ended June 30, 2026

WBest nffotiielimited CIN : 174'1 1 0DL1 992PLC1 1 6773 30luly 2026 National Stock Dxchange of India Limited BSE Limited Exchange Plaza, C-L, Block-G, 2Sth Floor, P.f. Towers, Bandra - Kurla Complex Dalal Street, Mumbai-400001 Bandra (E), Mumbai-40005 1 SCRIP CODE; 539660 SCRIP ID: BESTAGRO Subr Statement of Deviation or Variation in respect of Preferential Issue of Convertible Warrants for tle quarter ended lune 30. 2026. Dear Sir/Madam, Pursuant to Regulation 32(1) of the SEBI (Listing 0bligations and Disclosure Requirements) Regulations, 2015 as amended read with SEBI Circular No, CIR/CFD/CMDI/162/2019 dated December 24,2079, please find enclosed herewith the Statement of Deviation(s) or Variation(s) in respect of utilization of funds raised through Preferential Issue of Convertible Warrants for the quarter ended fune 30, 2025, Further, we hereby confirm that there is no deviation or variation in the utilisation offunds raised through Preferential Issue of Convertible Warrants. Please take the above information on record, -Thanking You, l,.,,,. JAIN OEFICER.CFO Place: New Delhi Date,30-07-2026 @ nega. Office & Corporole Office : B-4, Bhogwon Doss Nogor, Eost Puniobi Bogh, New Delhi-l 10026 Phon", 01 l-45803300 | Fox: 01 l-45093518 @ info@bestogrolife.com I www.bestogrolife.com MAKE IN INDIA Annexure.A Statement of Deviation / Variation in utilisation of funds raised Name of listed entity Best Agrolife Limited Mode of Fund Raising Preferential lssue of Convertible Warrants Date ofRaising Funds 27-t2-2024 Amount Raised 150 Cr Report filed for Quarter 30-05-2026 ended Monitoring Agency Applicable Monitoring Agency Name, if CRISIL RATINGS LIMITED applicable Is there a Deviation / No Variation in use of funds raised If yes, whether the same ls Not Applicable pursuant to change in terms of a confact or obiects, which was approved bythe shareholders If Yes, Date of shareholder Not Applicable Aooroval Explanation for the Deviation Not Applicable / Variation Comments of the Audit This statement as on June 30,2026 was reviewed and approved by the Audit Committee after review Committee at its meeting held on luly 30, 2026, Comments of tlte auditors, lf None Obf ects for which funds have been raised and where there has been a deviation, ln the following able Orlglnal Obiect Modified Obiect, Origina Modified Funds Amoun Remarks lf ifany I allocatio Utillse tof any Allocati n, d Deviati on if any on/ Variati on for quafte accordi applica obfect Capltal Expenditure The Board in its 50 0 0 0 Initial meeting held on revision of |une27,2026 took proceeds note ofthe lapse of from Rs. 70 warrants and crores to Rs, approved the 50 crores due forfeiture of the to non- initial amount of receipt of 137,50 crore unfront received by the money from Company, This Excello Fin leads to revision in Lea Limited the allocation of and Nova the issue proceeds Global and the same are 0pportunitie no longer available Fund, for utilization, Second revision in the cost of objects from Rs, 50 crores to 0 crores during reported quarte[ non- receipt balance 7570 warrants amount with- prescribed time. Working capital The Board in its 90 37,50 37.50 0 Initial meeting held on revision of lune 27,2026 took proceeds note ofthe lapse of from Rs, 120 warrants and crores to Rs, approved the 90 crores due forfeiture of the to non- initial amount of receipt of t37.50 crore upfront received by the money from Company, This Excello Fin leads to revision in Lea Limited t}te allocation of and Nova the issue proceeds Global and the same are Opportunitie no longer available Fund, for utilization, Second revision the cost of objects from Rs, 90 crores 37,50 crores during the reported quarten due non- receipt balance 75% warrants amount with' prescribed time. General Corporate Purpose The Board in its 10 0 0 0 Revision in meeting held on the cost of lune 27,2025 took objects from note of the lapse of Rs, 10 crores to 0 warrants and crores approved the ( --' during the A olif' forfeiture of the reforted initial amount of quarter, due o)l I -.-!r.drl}. {37,50 crore to non- receipt received by the of Company. This balance 75o/o leads to revision in warrants the allocation of amount with- the issue proceeds the and the same are prescribed no longer available time, for utilization, Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund-raising document i.e, prospectus, letter of offer, etc NOTE: a. The Company had originally issued 31,25,000 number of convertible warcants on preferential basls to the investors. However, lnvestors had subscribed 23,43,750 al an issue price of Rs. 640 each. Thercforc, original issue size is rcduced frcm Rs. 200 ctorcs to Rs. 150 crcres. b, Out of 150 crore of the proceeds the compony was required to receive Rs. 37,5 crore os upfront omount, However only Rs, 27 crore wos credited till December 26,2024. c. Out ol Rs. 37,5 crores belng the upfront 25% ol the proceeds, the company recelved remalnlng 76.5 crores durlng the quorter ended Morch 37,2025, d. No amount has been ralsed ond recetved by the compony durtng the quorter ended 3O-06-2026. Hence there ls no utiltsation during the qudrter, Entire utillsotion hos been completed durlng the quorter ended lune, 2025, e. ln terms of the conditions ol lssue of the warrants ond Regulation 169 ol the SEBI (lssue of Copttol ond Dlsclosure Requlrements) Regulotions, 2078 ('SEBI ICDR Regulotions"), the worront holders were entitled to exercise the option for conversion of the worronts tnto equlty shores wlthln o period of 18 (eighteen) months lrom the date of ollotment by poying the balance conslderotion, The sold converslon perlod explred on June 26, 2026, As the worrant holders folled to exerclse the converslon option ond dld not poy the bolonce conslderqtion withln the stlpuloted period, the Boord ol Dlredors, at lts meeting held on June 27, 2026, took note of the lopse ol worronts and opproved the lorfelture of the lnltial amount of 137,50 crore recelved by the Company ot the time of allotment ol the aforesold worronts, ln accordonce with the terms of lssue ol the worronts ond the opplicable provtslons ol the SEBI ICDR Regulations. iol-ru